
Access to medicines: Gavi should stop awarding special funds to Pfizer and GSK for pneumonia vaccine
Millions of children around the world remain vulnerable to pneumonia – the leading cause of childhood death – because of exploitative pricing by Pfizer and GSK Nearly one-third of the world’s countries have been unable












